fr   en
Fundraisings
Select a company :
Select an investor :
Choose date:
[<<]      «      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11      »      [23]
Date Company Amount Investors Planned use / Other
2009-12-16 Amsterdam Molecular Therapeutics (The Netherlands) € 5 million Forbion Capital Partners (The Netherlands) See details
2009-12-15 Hybrigenics (France) € 2.7 million   See details
2009-12-15 Molecular Partners (Switzerland) CHF 46 million (€ 30.4 million) Essex Woodlands Health Ventures (USA)
Index Ventures (Switzerland-GB)
Johnson & Johnson Development Corporation (USA)
BB Biotech Ventures (Switzerland)
Endeavour (Switzerland)
See details
2009-12-14 Evolva (Switzerland) CHF 44 million (€29 million) The first part of this Series B financing round, which was announced on 22 October 2009, yielded CHF 28 million. The second part closed on 11 December 2009 and yielded an additional CHF 16 million. Entrepreneurs Fund (UK)
Novartis Bioventures (Switzerland)
Dansk Innovation (Denmark)
Auriga Partners (France)
Wellington Partners (UK-Germany-Switzerland)
BioMedInvest (Switzerland)
Vinci Capital (Switzerland)
See details
2009-12-10 4SC AG (Germany) Kinaxo Biotechnologies (Germany) Virological Institute of the Erlangen University Hospital (Germany) € 700,000 Bavarian Research Foundation (Germany) See details
2009-12-10 Tigenix (Belgium) € 7.7 million   See details
2009-12-09 Polyplus-transfection (France) € 1.2 million CIC-Vizille Capital Innovation (France)
Avenir Finance Gestion (France)
CIC Finance-CIC Investissement Alsace (France)
See details
2009-12-09 Galapagos (Belgium) €902,564   See details
2009-12-03 arGEN-X (The Netherlands) €3 million + € 9.5 million Forbion Capital Partners (The Netherlands)
LSP (Life Sciences Partners) – (The Netherlands).
KBC Private Equity (Belgium)
BioGeneration Ventures (The Netherlands)
Erasmus MC Biomedical Fund (The Netherlands)
Thuja Capital Healthcare Funds (The Netherlands)
See details
2009-12-03 Movetis (Belgium) €85 million Both retail and institutional investors. See details
2009-12-01 Covagen (Switzerland)   Ventech (France) See details
2009-11-28 f-star (Austria-UK) € 3 million Novo A/S (Denmark) See details
2009-11-27 Reneuron (UK) £170,000   See details
2009-11-26 Reneuron (UK) £5 million Matrix Corporate Capital LLP See details
2009-11-26 Galapagos (Belgium) €1.2 million OSEO (France) See details
[<<]      «      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11      »      [23]